You have not yet registered? Get your account for free.
Forgot Password? We will send you a reset link
2 December 2022
Therma Bright investiert in die entwicklung neuartiger behandlungen für COVID-19, asthma und chronisch obstruktive lungenerkrankung (COPD)
5 November 2020
Therma Bright gründet neues Unternehmen namens Torion Biosciences zur Entwicklung seines COVID-19 Antigen-Schnelltests, CoviSafe(TM)
9 October 2020
Therma Bright und Orpheus Medica sichern Mitacs-Finanzierung zur Unterstützung ihres Forschungs- und Entwicklungsprogramms für COVID-19
4 September 2020
Therma Bright und Orpheus identifizieren neue biologische Nachweismoleküle für den COVID-19-Schnelltest
28 August 2020
Therma Bright schließt eine Vereinbarung mit Orpheus zur gemeinsamen Entwicklung des COVID-19 Speichel-Schnelltests von Orpheus Medica, CoviSafe(TM)
20 August 2020
Update von Therma Bright zu den Transaktionen Saringer und Orpheus
14 August 2020
Therma Bright Schließt Die Due-Diligence-Prüfung des COVID-19-Speichelschnelltests CoviSafe(TM) von Orpheus Medica Ab Und Geht in Phase 2 über
11 May 2020
Therma Bright Initiates Due Diligence to Manufacture Personal Protective Equipment, Hand Sanitizers and Applies for Government Grants
15 January 2020
Therma Bright Signs LOI to Acquire Benepod(R) Pain Relief Technology and Other Medical Device Technology from Saringer Life Science Technologies Inc.
5 September 2019
Therma Bright’s International Patent Application for TherOZap(TM) Enters National Phases in the US, Europe & Canada
4 September 2019
TherOZap(TM) Technology Test Results Prove Successful at Inhibiting Zika Virus During In-Vitro Tests
3 July 2019
Therma Bright Inc. Continues Testing of TherOZap(TM) Technology Against the Zika Virus
28 March 2019
Therma Bright Inc. in Final Stages of Testing TherOZap(TM) Technology Against the Zika Virus
1 November 2018
Therma Bright Inc. to Establish Subsidiary for Cannabis Related Devices
11 October 2018
Therma Bright Engages Top Virology Research Group to Conduct Further Tests of TherOZap(TM) Technology Against the Zika Virus
1 October 2018
Therma Bright Provides Corporate Update on Pain Relief Device Incorporating Medicinal Cannabis, Further Testing of TherOZap(TM) Technology Against the Zika Virus and Finalizes Multi-Use Activators
17 September 2018
Therma Bright Adds Strategic Advisor, Too Jae Min, Professor, Department of Anesthesiology and Pain Medicine, Korea University
19 June 2018
Therma Bright Inc. Adds Board Member, Provides Update and Option Grant
10 May 2018
Therma Bright Extends Closings of Financings and Completes Purchase of Domain Name ‘coldsores.com’
8 May 2018
Therma Bright to Test Thermal Therapy Technology with CBD and THC for Pain Relief and Adds Dr. Steven Bennett and Bruno Maruzzo as Strategic Advisors